Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential benefits. Early findings suggest that this higher dosage may amplify the drug's ability to regulate blood sugar, potentially offering greater outcomes for individuals with insulin resistance. Further investigation is underway to fully evaluate the lon